APA (7th ed.) Citation

Lévy, V., Lengline, E., & Chevret, S. (2026). When evaluating targeted therapies in chronic lymphocytic leukemia, the absolute measure of treatment effect should be preferred. Leukemia & Lymphoma, 67(7), 1527. https://doi.org/10.1080/10428194.2026.2647950

Chicago Style (17th ed.) Citation

Lévy, Vincent, Etienne Lengline, and Sylvie Chevret. "When Evaluating Targeted Therapies in Chronic Lymphocytic Leukemia, the Absolute Measure of Treatment Effect Should Be Preferred." Leukemia & Lymphoma 67, no. 7 (2026): 1527. https://doi.org/10.1080/10428194.2026.2647950.

MLA (9th ed.) Citation

Lévy, Vincent, et al. "When Evaluating Targeted Therapies in Chronic Lymphocytic Leukemia, the Absolute Measure of Treatment Effect Should Be Preferred." Leukemia & Lymphoma, vol. 67, no. 7, 2026, p. 1527, https://doi.org/10.1080/10428194.2026.2647950.